Literature DB >> 16761016

Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions.

S Verheyden, C Demanet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16761016     DOI： 10.1038/sj.leu.2404279

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.

Authors:  Romina Dastmalchi; Ali Farazmand; Sina Noshad; Mohamad Mozafari; Mahdi Mahmoudi; Alireza Esteghamati; Aliakbar Amirzargar
Journal:  Mol Biol Rep       Date:  2014-05-23       Impact factor: 2.316

Review 2.  Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.

Authors:  James O J Davies; Kate Stringaris; A John Barrett; Katayoun Rezvani
Journal:  Cytotherapy       Date:  2014-05-20       Impact factor: 5.414

3.  Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome.

Authors:  Issa F Khouri; Roland Bassett; Nancy Poindexter; Susan O'Brien; Carlos E Bueso-Ramos; Yvonne Hsu; Alessandra Ferrajoli; Michael J Keating; Richard Champlin; Marcelo Fernandez-Vina
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

4.  Killer cell immunoglobulin-like receptor gene cluster predisposes to susceptibility to B-cell acute lymphoblastic leukemia in Chinese children.

Authors:  Mingyan Jiang; Xia Guo; Lixing Yuan; Ju Gao; Li Huo; Qiang Li
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

5.  Natural killer cells modulation in hematological malignancies.

Authors:  Céline Baier; Aurore Fino; Carole Sanchez; Laure Farnault; Pascal Rihet; Brigitte Kahn-Perlès; Régis T Costello
Journal:  Front Immunol       Date:  2013-12-19       Impact factor: 7.561

Review 6.  Role of Distinct Natural Killer Cell Subsets in Anticancer Response.

Authors:  Helena Stabile; Cinzia Fionda; Angela Gismondi; Angela Santoni
Journal:  Front Immunol       Date:  2017-03-16       Impact factor: 7.561

Review 7.  Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.

Authors:  R J Boyton; D M Altmann
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

8.  Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.

Authors:  Zhihui Deng; Jun Zhao; Siqi Cai; Ying Qi; Qiong Yu; Maureen P Martin; Xiaojiang Gao; Rui Chen; Jiacai Zhuo; Jianxin Zhen; Mingjie Zhang; Guobin Zhang; Liumei He; Hongyan Zou; Liang Lu; Weigang Zhu; Wenxu Hong; Mary Carrington; Paul J Norman
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.